Genflow Biosciences PLC (GENF)

London
2.59
-0.01(-0.42%)
  • Volume:
    246,835
  • Bid/Ask:
    2.40/2.80
  • Day's Range:
    2.59 - 2.59

GENF Overview

Prev. Close
2.6
Day's Range
2.59-2.59
Revenue
-
Open
2.6
52 wk Range
2.03-13.5
EPS
-
Volume
246,835
Market Cap
7.61M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
878,766
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
292,506,618
Next Earnings Date
-
What is your sentiment on Genflow Biosciences?
or
Vote to see community's results!

Genflow Biosciences PLC Company Profile

Genflow Biosciences PLC Company Profile

Employees
2

Genflow Biosciences plc operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing or halting the ageing process, and reducing the incidence of age-related diseases with increase in health span. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. The company was incorporated in 2021 and is headquartered in London, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyNeutralSellSell
Technical IndicatorsBuySellSellSellSell
SummaryBuyNeutralNeutralSellSell